6Fouque D,Aparicio M.Eleven reasons to control the protein intake of patients with chronic kidney disease[J].Nat Clin Pract Nephrol,2007,3:383-392.
7Casas JP,Chua W,Loukogeorgakis S,et al.Effect of inhibi tors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes:systematic review and metaanalysis.Lancet,2005,366:2026-2033.
8Collins AJ,Kasiske B,Herzog C,et al.United States renal data system 2006 annual data report[J].Am J Kidney Dis,2007,49:s1-s296.
9Young EW,Albert JM,Satayathum S,et al.Predictors and consequences of altered mineral metabolism:the Dialysis Outcomes and Practice Patterns Study[J].Kidney Int,2005,67:1179-87.
10Wei M,Taskapan H,Esbaei K,et al.K/DOQI guideline requirements for calcium,phosphate,calcium phosphate product,and parathyroid hormone control in dialysis patients:can we achieve them?[J].Int Urol Nephrol,2006,38:739-743.